Overview

A Study of of MORAb-004 in Subjects With Solid Tumors

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of multiple intravenous infusions of MORAb-004.
Phase:
Phase 1
Details
Lead Sponsor:
Morphotek
Treatments:
Antibodies
Antibodies, Monoclonal
Immunoglobulins